| 王延桂高美华△.HER2阳性乳腺癌中CD44v6的表达与曲妥珠单抗耐药的关系[J].,2011,11(2):310-313 |
| HER2阳性乳腺癌中CD44v6的表达与曲妥珠单抗耐药的关系 |
| Relationship between Expression of CD44v6 and Resistance ofTrastuzumab Chemotheraphy in Metastatic Breast Cancer Patientswith HER2 Positive |
| |
| DOI： |
| 中文关键词: 乳腺癌 CD44v6 HER2 曲妥珠单抗 转移性乳腺癌 |
| 英文关键词: Breast cancer CD44v6 HER2 Trastuzumab Metastatic breast cancer |
| 基金项目: |
|
| 摘要点击次数: 678 |
| 全文下载次数: 989 |
| 中文摘要: |
| 目的：探讨曲妥珠单抗在治疗HER2 阳性的转移性乳腺癌时，产生耐药性与CD44v6表达的相关性。方法：共66例HER2 阳
性转移性乳腺癌患者入组。接受曲妥珠单抗治疗的患者37 例，其中18例获得了治疗前和治疗后转移性癌组织。采用免疫组化S
- P法对治疗前、治疗后的不同乳腺组织进行CD44v6表达的研究。结果：CD44v6在经曲妥珠单抗治疗产生耐药的活检组织中阳
性表达程度明显高于治疗前。结论：CD44v6的表达与曲妥珠单抗耐药相关。 |
| 英文摘要: |
| Objective: To explore the correlation between the expression of CD44v6 and resistance of trastuzumab chemotheraphy
for metastatic breast cancer patient with HER2 positive. Methods: 66 metastatic breast cancer patients with HER2 positive were eligible.
Among 66 patients, 37 were received trastuzumab，and there were 18 patients who had tumor tissues before and after therapy. All species
were analyzed by S-P immunohistochemical method using the monoclonal antibody CD44 v6. Results: CD44v6 in breast cancer tissues
of resistance to traszuzumab were signifcantly higher than before the treatment. Conclusion: There may be correlation between the
expression of CD44v6 and resistance to trastuzumab. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
